Efficacy and safety results from CheckMate 140, a phase 2 study of nivolumab for relapsed/refractory follicular lymphoma
Armand, Philippe, Janssens, Ann MH, Gritti, Giuseppe, Radford, John, Timmerman, John M, Pinto, Antonio, Mercadal Vilchez, Santiago, Johnson, P. W. M., Cunningham, David, Leonard, John P, Rodig, ScottJournal:
Blood
DOI:
10.1182/blood.2019004753
Date:
August, 2020
File:
PDF, 391 KB
2020